Acipimox

( DrugBank: Acipimox / KEGG DRUG: Acipimox )

2 diseases

ID	Disease name (Link within this page)	Number of trials
78	Hypopituitarism	2

ID	Disease name (Link within this page)	Number of trials
265	Lipodystrophy	1

78. Hypopituitarism

Clinical trials : 492 / Drugs : 341 - (DrugBank : 47) / Drug target genes : 45 - Drug target pathways : 100

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02782208 (ClinicalTrials.gov)	February 10, 2016	18/5/2016	Lipolytic Effects of GH in Hypopituitary Patients in Vivo	Lipolytic Effects of GH in Hypopituitary Patients in Vivo: Molecular Mechanisms and Temporal Pattern ...	Hypopituitarism;Insulin Resistance;Endocrine System Diseases;Glucose Metabolism Disorders;Metabolic ...	Drug: Acipimox;Drug: Placebo;Drug: GH substitution;Other: GH pause	University of Aarhus	NULL	Completed	18 Years	70 Years	Male	9	N/A	Denmark
2	NCT01209416 (ClinicalTrials.gov)	June 2012	24/9/2010	The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin	The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin	Metabolism;Insulin Resistance;Hypopituitarism	Drug: Acipimox;Drug: Ghrelin;Other: Placebo	University of Aarhus	NULL	Completed	18 Years	65 Years	Male	8	N/A	Denmark

Clinical trials : 112 / Drugs : 155 - (DrugBank : 55) / Drug target genes : 25 - Drug target pathways : 97

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00246402 (ClinicalTrials.gov)	September 2002	27/10/2005	Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV	Anti-Lipolytic Strategy for HIV Lipodystrophy	Insulin Resistance;Cardiovascular Diseases;Heart Diseases;HIV Infections;Hypertriglyceridemia;Hyperl ...	Drug: Acipimox	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Completed	18 Years	65 Years	Both	30	N/A	United States